Extensively Drug-Resistant Tuberculosis
Research from S.K. Sharma et al broadens understanding of extensively drug-resistant tuberculosis
Published in TB and Outbreaks Week, January 19th, 2010
"We sought to ascertain the prevalence of XDR-TB among patients with MDR-TB treated at a tertiary care centre in New Delhi, India. Case records of patients treated for MDR-TB at the All India Institute of Medical Sciences hospital, New Delhi, between 1997 and 2003 were retrospectively reviewed. All patients underwent a pretreatment drug-susceptibility testing (DST) to first- as well as second-line drugs. XDR-TB was defined as TB caused by bacilli showing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Burnham Institute
How flu succeeds - Jessica Jonap Public Relations
Incidence of type 1 diabetes doubles in 20 years, continues rising at 3 percent per year -- but why? - Johns Hopkins Medical Institutions
Early lessons from the H1N1 pandemic: Critical illness in children unpredictable but survivable - Johns Hopkins University Bloomberg School of Public Health
Researchers identify tuberculosis strain that thrives on antibiotic - Wiley-Blackwell
Efficacy of flu vaccine drastically reduced for RA patients treated with rituximab - Wiley-Blackwell
Insect cells provide the key to alternative swine flu vaccination - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
